本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Emergent Biosolutions

12.19
-0.1400-1.14%
盤前12.240.0514+0.42%08:00 EST
成交量:67.10萬
成交額:825.74萬
市值:6.40億
市盈率:9.02
高:12.63
開:12.25
低:12.08
收:12.33
52周最高:13.41
52周最低:4.02
股本:5,252.00萬
流通股本:5,125.71萬
量比:0.82
換手率:1.31%
股息:- -
股息率:- -
每股收益(TTM):1.35
每股收益(LYR):-3.5962
淨資產收益率:13.92%
總資產收益率:5.27%
市淨率:1.10
市盈率(LYR):-3.39

資料載入中...

公司資料

公司名字:
Emergent Biosolutions
交易所:
NYSE
成立時間:
1998
員工人數:
900
公司地址:
300 Professional Drive,Gaithersburg,Maryland,United States
郵編:
20879
電話:
傳真:
- -
簡介:
Emergent Biosolutions Inc.於1998年5月在美國密歇根州成立,隨後在 2004年6月改為特拉華公司。公司擁有兩個經營部門:生物防衛和生物科學。該公司是一家全球性生命科學公司,專註於提供創新的準備和響應解決方案,以應對意外、故意和自然發生的公共健康威脅。

董事

名稱
職位
Joseph C. Papa
Chief Executive Officer, Director and President
Zsolt Harsanyi
Chairman of the Board
Donald DeGolyer
Independent Director
Kathryn C. Zoon
Independent Director
Keith Katkin
Independent Director
Marvin L. White
Independent Director
Neal Fowler
Independent Director
Ronald B. Richard
Independent Director
Sujata Dayal
Independent Director

股東

名稱
職位
Joseph C. Papa
Chief Executive Officer, Director and President
Jessica Perl
Senior Vice President, General Counsel and Corporate Secretary
Paul Williams
Senior Vice President, Products Business
Richard S. Lindahl
Executive Vice President, Chief Financial Officer and Treasurer
William Hartzel
Senior Vice President, Manufacturing and Bioservices
Coleen Glessner
Executive Vice President, Quality and Ethics and Compliance
Simon Lowry
Chief Medical Officer, Head of Research and Development